English
简体中文
Total: £ 56.28
Published Date: 2026-03-16 | Pages: 125 | Tables: 118 | Pharma & Healthcare
The global Capecitabine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Capecitabine Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Capecitabine Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Capecitabine Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Capecitabine Tablets include Roche, Teva Pharmaceutical, Accord Healthcare, Dr. Reddy's Laboratories, Eugia Pharma, Sun Pharma, Qilu Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Shanghai Sine Pharmaceutical, Chengdu Easton Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Capecitabine Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Capecitabine Tablets. The Capecitabine Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Capecitabine Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Capecitabine Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Teva Pharmaceutical
Accord Healthcare
Dr. Reddy's Laboratories
Eugia Pharma
Sun Pharma
Qilu Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Shanghai Sine Pharmaceutical
Chengdu Easton Biopharmaceuticals
Shandong New Time Pharmaceutical
Segment by Type
150mg
500mg
by Application
Colon Cancer
Breast Cancer
Stomach Cancer
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Capecitabine Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Capecitabine Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Capecitabine Tablets Market Overview
1.1 Product Definition
1.2 Capecitabine Tablets by Type
1.2.1 Global Capecitabine Tablets Market Value by Type: 2025 vs 2032
1.2.2 150mg
1.2.3 500mg
1.3 Capecitabine Tablets by Application
1.3.1 Global Capecitabine Tablets Market Value by Application: 2025 vs 2032
1.3.2 Colon Cancer
1.3.3 Breast Cancer
1.3.4 Stomach Cancer
1.4 Global Capecitabine Tablets Market Size Estimates and Forecasts
1.4.1 Global Capecitabine Tablets Revenue 2021–2032
1.4.2 Global Capecitabine Tablets Sales 2021–2032
1.4.3 Global Capecitabine Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Capecitabine Tablets Market Competition by Manufacturers
2.1 Global Capecitabine Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Capecitabine Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Capecitabine Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Capecitabine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Capecitabine Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Capecitabine Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Capecitabine Tablets, Date of Entry into the Industry
2.8 Global Capecitabine Tablets Market Competitive Situation and Trends
2.8.1 Global Capecitabine Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Capecitabine Tablets Players Market Share by Revenue
2.8.3 Global Capecitabine Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Capecitabine Tablets Market Scenario by Region
3.1 Global Capecitabine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Capecitabine Tablets Sales by Region: 2021–2032
3.2.1 Global Capecitabine Tablets Sales by Region: 2021–2026
3.2.2 Global Capecitabine Tablets Sales by Region: 2027–2032
3.3 Global Capecitabine Tablets Revenue by Region: 2021–2032
3.3.1 Global Capecitabine Tablets Revenue by Region: 2021–2026
3.3.2 Global Capecitabine Tablets Revenue by Region: 2027–2032
3.4 North America Capecitabine Tablets Market Facts & Figures by Country
3.4.1 North America Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Capecitabine Tablets Sales by Country (2021–2032)
3.4.3 North America Capecitabine Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Capecitabine Tablets Market Facts & Figures by Country
3.5.1 Europe Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Capecitabine Tablets Sales by Country (2021–2032)
3.5.3 Europe Capecitabine Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Capecitabine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Capecitabine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Capecitabine Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Capecitabine Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Capecitabine Tablets Market Facts & Figures by Country
3.7.1 Latin America Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Capecitabine Tablets Sales by Country (2021–2032)
3.7.3 Latin America Capecitabine Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Capecitabine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Capecitabine Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Capecitabine Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Capecitabine Tablets Sales by Type (2021–2032)
4.1.1 Global Capecitabine Tablets Sales by Type (2021–2026)
4.1.2 Global Capecitabine Tablets Sales by Type (2027–2032)
4.1.3 Global Capecitabine Tablets Sales Market Share by Type (2021–2032)
4.2 Global Capecitabine Tablets Revenue by Type (2021–2032)
4.2.1 Global Capecitabine Tablets Revenue by Type (2021–2026)
4.2.2 Global Capecitabine Tablets Revenue by Type (2027–2032)
4.2.3 Global Capecitabine Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Capecitabine Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Capecitabine Tablets Sales by Application (2021–2032)
5.1.1 Global Capecitabine Tablets Sales by Application (2021–2026)
5.1.2 Global Capecitabine Tablets Sales by Application (2027–2032)
5.1.3 Global Capecitabine Tablets Sales Market Share by Application (2021–2032)
5.2 Global Capecitabine Tablets Revenue by Application (2021–2032)
5.2.1 Global Capecitabine Tablets Revenue by Application (2021–2026)
5.2.2 Global Capecitabine Tablets Revenue by Application (2027–2032)
5.2.3 Global Capecitabine Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Capecitabine Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Capecitabine Tablets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Company Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Accord Healthcare
6.3.1 Accord Healthcare Company Information
6.3.2 Accord Healthcare Description and Business Overview
6.3.3 Accord Healthcare Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Accord Healthcare Capecitabine Tablets Product Portfolio
6.3.5 Accord Healthcare Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Company Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 Eugia Pharma
6.5.1 Eugia Pharma Company Information
6.5.2 Eugia Pharma Description and Business Overview
6.5.3 Eugia Pharma Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eugia Pharma Capecitabine Tablets Product Portfolio
6.5.5 Eugia Pharma Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Company Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharma Capecitabine Tablets Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.7.1 Qilu Pharmaceutical Company Information
6.7.2 Qilu Pharmaceutical Description and Business Overview
6.7.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Chia Tai-Tianqing Pharmaceutical
6.8.1 Chia Tai-Tianqing Pharmaceutical Company Information
6.8.2 Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.8.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
6.8.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.9 Shanghai Sine Pharmaceutical
6.9.1 Shanghai Sine Pharmaceutical Company Information
6.9.2 Shanghai Sine Pharmaceutical Description and Business Overview
6.9.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
6.9.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.10 Chengdu Easton Biopharmaceuticals
6.10.1 Chengdu Easton Biopharmaceuticals Company Information
6.10.2 Chengdu Easton Biopharmaceuticals Description and Business Overview
6.10.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
6.10.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
6.11 Shandong New Time Pharmaceutical
6.11.1 Shandong New Time Pharmaceutical Company Information
6.11.2 Shandong New Time Pharmaceutical Description and Business Overview
6.11.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
6.11.5 Shandong New Time Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Capecitabine Tablets Industry Chain Analysis
7.2 Capecitabine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Capecitabine Tablets Production Mode & Process Analysis
7.4 Capecitabine Tablets Sales and Marketing
7.4.1 Capecitabine Tablets Sales Channels
7.4.2 Capecitabine Tablets Distributors
7.5 Capecitabine Tablets Customer Analysis
8 Capecitabine Tablets Market Dynamics
8.1 Capecitabine Tablets Industry Trends
8.2 Capecitabine Tablets Market Drivers
8.3 Capecitabine Tablets Market Challenges
8.4 Capecitabine Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Capecitabine Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Capecitabine Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Capecitabine Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Capecitabine Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Capecitabine Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Capecitabine Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Capecitabine Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Capecitabine Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Capecitabine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Capecitabine Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Capecitabine Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Capecitabine Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Capecitabine Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Capecitabine Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Capecitabine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Capecitabine Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Capecitabine Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Capecitabine Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Capecitabine Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Capecitabine Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Capecitabine Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Capecitabine Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Capecitabine Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Capecitabine Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Capecitabine Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Capecitabine Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Capecitabine Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Capecitabine Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Capecitabine Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Capecitabine Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Capecitabine Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Capecitabine Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Capecitabine Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Capecitabine Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Capecitabine Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Capecitabine Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Capecitabine Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Capecitabine Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Capecitabine Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Capecitabine Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Capecitabine Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Capecitabine Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Capecitabine Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Capecitabine Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Capecitabine Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Capecitabine Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Capecitabine Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Capecitabine Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Capecitabine Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Capecitabine Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Capecitabine Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Capecitabine Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Capecitabine Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Capecitabine Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Capecitabine Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Capecitabine Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Capecitabine Tablets Product
Table 74. Roche Recent Developments/Updates
Table 75. Teva Pharmaceutical Company Information
Table 76. Teva Pharmaceutical Description and Business Overview
Table 77. Teva Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva Pharmaceutical Capecitabine Tablets Product
Table 79. Teva Pharmaceutical Recent Developments/Updates
Table 80. Accord Healthcare Company Information
Table 81. Accord Healthcare Description and Business Overview
Table 82. Accord Healthcare Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Accord Healthcare Capecitabine Tablets Product
Table 84. Accord Healthcare Recent Developments/Updates
Table 85. Dr. Reddy's Laboratories Company Information
Table 86. Dr. Reddy's Laboratories Description and Business Overview
Table 87. Dr. Reddy's Laboratories Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Dr. Reddy's Laboratories Capecitabine Tablets Product
Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
Table 90. Eugia Pharma Company Information
Table 91. Eugia Pharma Description and Business Overview
Table 92. Eugia Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eugia Pharma Capecitabine Tablets Product
Table 94. Eugia Pharma Recent Developments/Updates
Table 95. Sun Pharma Company Information
Table 96. Sun Pharma Description and Business Overview
Table 97. Sun Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sun Pharma Capecitabine Tablets Product
Table 99. Sun Pharma Recent Developments/Updates
Table 100. Qilu Pharmaceutical Company Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Qilu Pharmaceutical Capecitabine Tablets Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Chia Tai-Tianqing Pharmaceutical Company Information
Table 106. Chia Tai-Tianqing Pharmaceutical Description and Business Overview
Table 107. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product
Table 109. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 110. Shanghai Sine Pharmaceutical Company Information
Table 111. Shanghai Sine Pharmaceutical Description and Business Overview
Table 112. Shanghai Sine Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Sine Pharmaceutical Capecitabine Tablets Product
Table 114. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 115. Chengdu Easton Biopharmaceuticals Company Information
Table 116. Chengdu Easton Biopharmaceuticals Description and Business Overview
Table 117. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product
Table 119. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 120. Shandong New Time Pharmaceutical Company Information
Table 121. Shandong New Time Pharmaceutical Description and Business Overview
Table 122. Shandong New Time Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Shandong New Time Pharmaceutical Capecitabine Tablets Product
Table 124. Shandong New Time Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Capecitabine Tablets Distributors List
Table 128. Capecitabine Tablets Customers List
Table 129. Capecitabine Tablets Market Trends
Table 130. Capecitabine Tablets Market Drivers
Table 131. Capecitabine Tablets Market Challenges
Table 132. Capecitabine Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Capecitabine Tablets
Figure 2. Global Capecitabine Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Capecitabine Tablets Market Share by Type: 2025 & 2032
Figure 4. 150mg Product Picture
Figure 5. 500mg Product Picture
Figure 6. Global Capecitabine Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Capecitabine Tablets Market Share by Application: 2025 & 2032
Figure 8. Colon Cancer
Figure 9. Breast Cancer
Figure 10. Stomach Cancer
Figure 11. Global Capecitabine Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Capecitabine Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Capecitabine Tablets Sales (K Units), 2021–2032
Figure 14. Global Capecitabine Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Capecitabine Tablets Report Years Considered
Figure 16. Capecitabine Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Capecitabine Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Capecitabine Tablets Players: Market Share by Revenue in Capecitabine Tablets in 2025
Figure 19. Capecitabine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Capecitabine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Capecitabine Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Capecitabine Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Capecitabine Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Capecitabine Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Capecitabine Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Capecitabine Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Capecitabine Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Capecitabine Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Capecitabine Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Capecitabine Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Capecitabine Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Capecitabine Tablets by Type (2021–2032)
Figure 54. Global Capecitabine Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Capecitabine Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Capecitabine Tablets by Application (2021–2032)
Figure 57. Global Capecitabine Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Capecitabine Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
